Profund Advisors’s Immunogen Inc IMGN Stock Holding History

Profund Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54,327	Closed	-$1.61M	–	1208
2023 Q4	$1.61M	Sell	54,327 -43,837	-45%	-$873K	0.07%	222
2023 Q3	$1.56M	Buy	98,164 +33,449	+52%	+$556K	0.09%	181
2023 Q2	$1.22M	Sell	64,715 -188,111	-74%	-$2.22M	0.07%	271
2023 Q1	$971K	Buy	+252,826	New	+$1.08M	0.06%	309

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Profund Advisors's IMGN Position: Q1 2024 in Review

Profund Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 54,327 shares — an estimated $1.61M sold.

Profund Advisors first reported a position in IMGN in Q1 2023 and held it in 4 quarters. The position peaked at $1.61M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Profund Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Profund Advisors sold 54,327 Immunogen Inc shares in Q1 2024, an estimated $1.61M.
Profund Advisors first reported a position in Immunogen Inc in Q1 2023 and held it in 4 quarters.
Profund Advisors's Immunogen Inc position peaked at $1.61M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.